CSNK2A2 and cancer: Consistent with the involvement of microtubules and CSNK2 in late stages of cancer, overexpression of CSNK2A2 is associated with poor prognosis in ovarian cancer [43], while its inhibition reduces tumor growth and metastatic colonization [44].